Assicurazioni Generali (ARZGY) Price & Analysis

Compare

38 Followers

ARZGY Stock Chart & Stats

Day’s Range― - ―

52-Week Range$13.37 - $20.23

Previous CloseN/A

Volume5.07K

Average Volume (3M)1.88K

Market Cap

$60.30B

Enterprise Value$102.20B

Total Cash (Recent Filing)$6.95B

Total Debt (Recent Filing)$36.01B

Price to Earnings (P/E)14.4

Beta0.38

Next Earnings

Nov 13, 2025

EPS EstimateN/A

Last Dividend Ex-Date

May 20, 2025

Dividend Yield4.17%

Share Statistics

EPS (TTM)0.85

Shares Outstanding3,099,569,800

10 Day Avg. Volume2,619

30 Day Avg. Volume1,876

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.69

Enterprise Value/Revenue1.93

Enterprise Value/Gross Profit1.33

Enterprise Value/Ebitda-64.85

Forecast

1Y Price Target

$22.00

Price Target Upside14.52% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering0

Assicurazioni Generali News

Generali resumed with an Overweight at Morgan Stanley

Morgan Stanley analyst Hadley Cohen resumed coverage of Generali (ARZGY) with an Overweight rating and EUR 37.50 price...

21d ago

Generali price target raised to EUR 39 from EUR 37 at JPMorgan

JPMorgan raised the firm’s price target on Generali (ARZGY) to EUR 39 from EUR 37 and keeps an...

1M ago

Generali SpA’s Earnings Call Highlights Strong Growth

Assicurazioni Generali SpA (($ARZGY)) has held its Q2 earnings call. Read on for the main highlights of the...

2M ago

Generali Reports Strong Growth in H1 2025

Assicurazioni Generali SpA ( ($ARZGY) ) has released its Q2 earnings. Here is a breakdown of the information...

2M ago

UniCredit reduces stake in Generali, Bloomberg says

UniCredit (UNCRY) has recently begun reducing its stake in Assicurazioni Generali (ARZGY) as part of its plan to...

3M ago

Generali upgraded to Overweight from Neutral at JPMorgan

JPMorgan upgraded Generali (ARZGY) to Overweight from Neutral with a price target of EUR 37, up from EUR...

3M ago

Generali upgraded to Market Perform from Underperform at Keefe Bruyette

Keefe Bruyette upgraded Generali (ARZGY) to Market Perform from Underperform with a EUR 30 price target Published first...

4M ago

Generali price target raised to EUR 34 from EUR 32 at JPMorgan

JPMorgan raised the firm’s price target on Generali (ARZGY) to EUR 34 from EUR 32 and keeps a...

4M ago

Generali SpA’s Earnings Call: Strong Start Amid Challenges

Assicurazioni Generali SpA (($ARZGY)) has held its Q1 earnings call. Read on for the main highlights of the...

4M ago

Generali price target raised to EUR 36.10 from EUR 34.80 at Berenberg

Berenberg raised the firm’s price target on Generali (ARZGY) to EUR 36.10 from EUR 34.80 and keeps a...

4M ago

Generali downgraded to Underperform from Neutral at Oddo BHF

Oddo BHF analyst Benoit Valleaux downgraded Generali (ARZGY) to Underperform from Neutral with a EUR 32 price target...

4M ago

Generali Reports Strong Growth in Q1 2025

Assicurazioni Generali SpA ( ($ARZGY) ) has released its Q1 earnings. Here is a breakdown of the information...

4M ago

Generali price target raised to EUR 32 from EUR 31 at JPMorgan

JPMorgan raised the firm’s price target on Generali (ARZGY) to EUR 32 from EUR 31 and keeps a...

5M ago

Generali price target lowered to EUR 33.50 from EUR 33.80 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Generali (ARZGY) to EUR 33.50 from EUR 33.80 and keeps...

5M ago

ARZGY FAQ

What was Assicurazioni Generali’s price range in the past 12 months?

Assicurazioni Generali lowest stock price was $13.37 and its highest was $20.23 in the past 12 months.

What is Assicurazioni Generali’s market cap?

Assicurazioni Generali’s market cap is $60.30B.

When is Assicurazioni Generali’s upcoming earnings report date?

Assicurazioni Generali’s upcoming earnings report date is Nov 13, 2025 which is in 49 days.

How were Assicurazioni Generali’s earnings last quarter?

Assicurazioni Generali released its earnings results on Aug 06, 2025. The company reported $0.855 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.005.

Is Assicurazioni Generali overvalued?

According to Wall Street analysts Assicurazioni Generali’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Assicurazioni Generali pay dividends?

Assicurazioni Generali pays a Annually dividend of $0.809 which represents an annual dividend yield of 4.17%. See more information on Assicurazioni Generali dividends here

What is Assicurazioni Generali’s EPS estimate?

Assicurazioni Generali’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Assicurazioni Generali have?

Assicurazioni Generali has 3,099,569,800 shares outstanding.

What happened to Assicurazioni Generali’s price movement after its last earnings report?

Assicurazioni Generali reported an EPS of $0.855 in its last earnings report, beating expectations of $0.85. Following the earnings report the stock price went up 2.818%.

Which hedge fund is a major shareholder of Assicurazioni Generali?

Currently, no hedge funds are holding shares in ARZGY

Assicurazioni Generali Stock Smart Score

Neutral

Fundamentals

Return on Equity

12.68%

Trailing 12-Months

Asset Growth

13.86%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Assicurazioni Generali

Assicurazioni Generali, commonly known as Generali, is a leading global insurance and financial services company headquartered in Trieste, Italy. Founded in 1831, it operates across various sectors including life insurance, property and casualty insurance, and asset management. Generali serves millions of customers worldwide, offering a diverse range of products such as life insurance policies, health insurance, retirement solutions, and investment products aimed at both individual and corporate clients.

Assicurazioni Generali (ARZGY) Earnings & Revenues

Historic Earnings Reports

ARZGY Company Deck

ARZGY Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Generali's first half 2025 results show strong growth in operating results and strategic advancements, notably in P&C and Life segments, supported by a share buyback program. While the solvency ratio was below expectations and tax rates increased, these challenges are outweighed by the company's robust performance and strategic initiatives.View all ARZGY earnings summaries